ClinicalTrials.Veeva

Menu

Pacemaker-based Long-term Monitoring of Sleep Apnea (ACaSA)

M

Medical University Innsbruck

Status

Enrolling

Conditions

Bradycardia

Study type

Observational

Funder types

Other

Identifiers

NCT05127720
1322/2020

Details and patient eligibility

About

This is a prospective, non-interventional cohort study. It tests the hypothesis that

  • Pacemaker-derived monitoring of sleep-related breathing disorders and/or daily physical activity predicts clinical outcome.
  • Autonomic imbalance defined by an increased periodic repolarisation dynamics (PRD) predicts clinical outcome in pacemaker patients.
  • Autonomic imbalance defined by an increased periodic repolarisation dynamics (PRD) predicts the occurrence of AHRE in SR patients implanted with a DDDR pacemaker.

Full description

All forms of arrhythmias, sleep apnea during sleeping hours and physical activity using sensors in modern implanted pacemakers as well as autonomic imbalance measures will be correlated with the incidence and progression (within 5 years of follow-up) of common co-morbidities such as arterial hypertension, coronary artery disease, heart failure, COPD, peripheral artery disease, iron insufficiency. In a long follow up perspective major adverse cardiovascular events will be recorded and new risk scores will be developed, incorporating machine learning techniques.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • implanted Microport TEO SR/DR or BOREA SR/DR pacemaker device
  • signed informed consent

Exclusion criteria

  • any contraindication to perform a cardiac CT examination
  • eGFR < 30 ml/min/1.73 m2
  • allergy against CT contrast medium
  • hyperthyreoism
  • inability of the patient to understand the study purpose and plan
  • inability of the patient to perform baseline examinations
  • pregnancy or breast-feeding; women with childbearing potential
  • estimated life expectancy below one year

Trial design

300 participants in 3 patient groups

patients with severe sleep apnea
Description:
defined by a pacemaker-derived mean RDI ≥ 20/h in the first 12 months after enrollment
patients with autonomic imbalance
Description:
defined by PRD ≥ 5.75deg2 assessed within the first 12 months of enrollment
patients with a sedentary lifestyle
Description:
defined by a pacemaker-derived mean daily physical activity level \< 2h in the first 12 months after enrollment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems